| 1 |
2022 |
2021 GRAPPA Trainee Symposium: A Summary of Oral and Poster Presentations. |
PsA, PsD |
| 2 |
2022 |
Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. |
--- |
| 3 |
2022 |
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). |
ASAS, AXIS, CASPAR, PsA |
| 4 |
2022 |
Basic Science Session 1. Biomarkers for Psoriatic Arthritis Treatment Response and Joint Damage Progression: An Update on 2 Industry-GRAPPA Projects. |
--- |
| 5 |
2022 |
Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis. |
IL, PsA |
| 6 |
2022 |
Challenges in the Diagnosis and Assessment of Psoriatic Arthritis. |
PsA, PsO |
| 7 |
2022 |
Clinical Controversies in Psoriatic Disease: The Use of IL-17i/IL-23i Versus TNFi as First-line Advanced Therapy in Psoriatic Arthritis. |
IL, PsA |
| 8 |
2022 |
COVID-19 Update for the GRAPPA 2021 Annual Meeting: Focus on COVID-19 Vaccination. |
AIRDs, COVID-19 |
| 9 |
2022 |
GRAPPA 2020 Research Award Recipients. |
--- |
| 10 |
2022 |
GRAPPA Treatment Recommendations: 2021 Update. |
PsA |
| 11 |
2022 |
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. |
PsA |
| 12 |
2022 |
Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. |
AS, axPsA, IBP, IL, PsA |
| 13 |
2022 |
Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. |
IL-17, RCTs |
| 14 |
2022 |
Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. |
PsA |
| 15 |
2022 |
Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. |
GRADE |
| 16 |
2022 |
Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. |
bDMARDs, csDMARDs, GRADE, IL-17i, JAKi, PsA, RCTs, TNFi |
| 17 |
2022 |
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. |
CVD, PsA |
| 18 |
2022 |
Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group. |
PsA |
| 19 |
2022 |
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting. |
AMP AIM, CRN, HIPPOCRATES, PsA |
| 20 |
2022 |
Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). |
OMERACT, PsD |
| 21 |
2022 |
Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases. |
DEI, PsD, PsO |
| 22 |
2022 |
Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting. |
IDEOM, PsA, PsO |
| 23 |
2022 |
Toward a Sonographic Composite Index for Diagnosis in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop. |
DUET, PsA |
| 24 |
2022 |
Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. |
GRADE, IL-17i, PsA, PsO, TNFi |
| 25 |
2022 |
Young-GRAPPA at the Annual GRAPPA Meeting: Presentation of a New Group Within GRAPPA and Its Vision. |
--- |
| 26 |
2021 |
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study. |
CPDAI, DAS28, ES, PROMs, PsA, sCPDAI, SRM, VAS |
| 27 |
2021 |
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study. |
CPDAI, DAS28, ES, PROMs, PsA, sCPDAI, SRM, VAS |
| 28 |
2021 |
GRAPPA 2019 Research Recipient Awards Report. |
--- |
| 29 |
2021 |
GRAPPA 2019 Research Recipient Awards Report. |
--- |
| 30 |
2021 |
GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting. |
COVID-19, OMERACT, PRPs |
| 31 |
2021 |
GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting. |
COVID-19, OMERACT, PRPs |
| 32 |
2021 |
GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations. |
--- |
| 33 |
2021 |
GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations. |
--- |
| 34 |
2021 |
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting. |
PsA |
| 35 |
2021 |
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting. |
PsA |
| 36 |
2021 |
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. |
PsA |
| 37 |
2021 |
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. |
PsA |
| 38 |
2021 |
Magnetic Resonance Imaging of Axial and Peripheral Disease in Psoriatic Arthritis: A Report From the 2020 GRAPPA Annual Meeting. |
MRI, PsA |
| 39 |
2021 |
Magnetic Resonance Imaging of Axial and Peripheral Disease in Psoriatic Arthritis: A Report From the 2020 GRAPPA Annual Meeting. |
MRI, PsA |
| 40 |
2021 |
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF. |
HAQ-DI, PsA, SLRs, SOMP, TAG |
| 41 |
2021 |
Overview of the Grant Writing Workshop From the GRAPPA 2020 Annual Meeting. |
--- |
| 42 |
2021 |
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. |
AMP, CRN, eCRFs, IMI, OPAL, PsA, SOPs |
| 43 |
2021 |
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. |
AMP, CRN, eCRFs, IMI, OPAL, PsA, SOPs |
| 44 |
2021 |
Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). |
OMERACT |
| 45 |
2021 |
Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). |
COVID-19, OMERACT |
| 46 |
2021 |
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. |
COVID-19, PsD |
| 47 |
2021 |
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. |
COVID-19, PsD |
| 48 |
2021 |
Pustular Psoriasis and Associated Musculoskeletal Disorders. |
GPP, PsA, PsO, SAPHO |
| 49 |
2021 |
Pustular Psoriasis and Associated Musculoskeletal Disorders. |
PsA, PsO, SAPHO |
| 50 |
2021 |
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting. |
IDEOM, PsO |
| 51 |
2021 |
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting. |
IDEOM, PsO |
| 52 |
2021 |
The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop. |
PsA, US |
| 53 |
2021 |
The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop. |
PsA, US |
| 54 |
2021 |
Updates on Axial Psoriatic Arthritis From the 2020 GRAPPA Annual Meeting. |
axPsA |
| 55 |
2021 |
Updates on Axial Psoriatic Arthritis From the 2020 GRAPPA Annual Meeting. |
axPsA |
| 56 |
2020 |
GRAPPA 2019 Project Report. |
OMERACT |
| 57 |
2020 |
GRAPPA Trainees Symposium 2019: A Report from the GRAPPA 2019 Annual Meeting. |
--- |
| 58 |
2020 |
Methotrexate in Psoriasis and Psoriatic Arthritis. |
MTX, PsA |
| 59 |
2020 |
Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). |
PsA, US |
| 60 |
2020 |
Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting. |
IDEOM, PsA |
| 61 |
2020 |
The Diagnosis and Treatment of Adult Patients with SAPHO Syndrome: Controversies Revealed in a Multidisciplinary International Survey of Physicians. |
--- |
| 62 |
2020 |
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. |
PsA |
| 63 |
2020 |
[Treatment strategies in psoriatic arthritis]. |
EULAR |
| 64 |
2019 |
Best-practice Indicators in Psoriatic Disease Care. |
PsA |
| 65 |
2019 |
Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis. |
CV |
| 66 |
2019 |
GRAPPA 2018 Project Report. |
--- |
| 67 |
2019 |
GRAPPA Trainees Symposium 2018: A Report from the GRAPPA 2018 Annual Meeting. |
--- |
| 68 |
2019 |
Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. |
BioDAM, PsA |
| 69 |
2019 |
Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). |
IDEOM, OMERACT, PsA |
| 70 |
2019 |
Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting. |
IDEOM, PPACMAN |
| 71 |
2019 |
The Genetics of Psoriasis and Psoriatic Arthritis. |
PsA, PsC, TNFi |
| 72 |
2019 |
The GRAPPA Sonographic Enthesitis Workshop. |
PsA, US |
| 73 |
2019 |
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. |
PsA |
| 74 |
2019 |
Treatment of psoriatic arthritis : Are there differential indications? |
EULAR, MDA, PsA |
| 75 |
2018 |
Classification and Outcome Measures for Psoriatic Arthritis. |
LOS, PsA, RCTs |
| 76 |
2018 |
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting. |
FACIT, HAQ-DI, PsA, PsAID, SPARCC |
| 77 |
2018 |
GRAPPA 2017 Project Report. |
app |
| 78 |
2018 |
GRAPPA Trainees Symposium 2017: A Report from the GRAPPA 2017 Annual Meeting. |
--- |
| 79 |
2018 |
Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting. |
CRN, PsA |
| 80 |
2018 |
Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). |
PRP, PsA |
| 81 |
2018 |
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials. |
HRQoL, LOS, OMERACT, PRP, PsA, RCT |
| 82 |
2018 |
Psoriatic Arthritis Sonographic Enthesitis Instruments: A Systematic Review of the Literature. |
OMERACT, PsA, SpA |
| 83 |
2018 |
Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting. |
IDEOM, PASI, PsA |
| 84 |
2018 |
The Benefits and Challenges of Setting Up a Longitudinal Psoriatic Arthritis Database. |
--- |
| 85 |
2018 |
The Microbiome in Psoriasis and Psoriatic Arthritis: Joints. |
--- |
| 86 |
2018 |
The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting. |
PRP, PsA |
| 87 |
2018 |
Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set. |
ACR, CRP, ESR, PsA, RCT |
| 88 |
2017 |
Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting. |
PsA |
| 89 |
2017 |
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group. |
PsA |
| 90 |
2017 |
GRAPPA 2016 Project Report. |
--- |
| 91 |
2017 |
GRAPPA Trainees Symposium 2016: A Report from the GRAPPA 2016 Annual Meeting. |
--- |
| 92 |
2017 |
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. |
MDA, OMERACT, PsA, VLDA |
| 93 |
2017 |
International Treatment Recommendations Update: A Report from the GRAPPA 2016 Annual Meeting. |
--- |
| 94 |
2017 |
Nail Enthesis Ultrasound in Psoriasis and Psoriatic Arthritis: A Report from the 2016 GRAPPA Annual Meeting. |
PD, PsA |
| 95 |
2017 |
Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting. |
--- |
| 96 |
2017 |
Proceedings of the GRAPPA 2016 Retreat. |
--- |
| 97 |
2017 |
Prologue: 2016 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). |
PsA |
| 98 |
2017 |
Tackling Patient Centricity: A Report from the GRAPPA 2016 Annual Meeting. |
PRP |
| 99 |
2017 |
The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial. |
AUC, CPDAI, PASDAS, PsA, SC, TC, TICOPA |
| 100 |
2017 |
Treatments for Psoriatic Arthritis, a Guide for Patients Written by Fellow Patients: A Report from the GRAPPA 2016 Annual Meeting. |
PRP |
A Search Service for Abbreviation / Long Form
